The study is said to be the first to demonstrate efficacy for FcRn inhibition in SLE.

The results provide validation of the DPP1 inhibition in bronchiectasis and reinforce the drug class’s position in this ...

PALM BEACH, FL, United States – 4th June 2026 – JFB Construction Holdings reported that XTEND, the company with which it has ...

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a global leader ...

Agilis Air, Inc., a portfolio company of the YBI Engine Tech Incubator, has been selected as a Phase II Qualifier for the U.S ...

Use Attack Drone is part of the next generation of American-built one-way attack drones Powerus recently announced a ...

HYDERABAD: The state government has approved Phase-II of the Comprehensive Road Maintenance Programme (CRMP) in the Core ...

Au Skarn target footprint grows from ~300 metres to a 2.5-kilometre prospective lithological-magnetic corridor (see Figure 2) ...

A total of 35 patients were enrolled and treated, and the median lines of previous treatment were 2 (range, 0-4). The confirmed CNS-ORR was 77.1% (27/35, 95% CI, 59.9 to 89.6), and the CNS-CBR was ...